Literature DB >> 31845781

Influenza: Diagnosis and Treatment.

David Y Gaitonde1, Faith C Moore1, Mackenzie K Morgan1.   

Abstract

Influenza is an acute viral respiratory infection that causes significant morbidity and mortality worldwide. Three types of influenza cause disease in humans. Influenza A is the type most responsible for causing pandemics because of its high susceptibility to antigenic variation. Influenza is highly contagious, and the hallmark of infection is abrupt onset of fever, cough, chills or sweats, myalgias, and malaise. For most patients in the outpatient setting, the diagnosis is made clinically, and laboratory confirmation is not necessary. Laboratory testing may be useful in hospitalized patients with suspected influenza and in patients for whom a confirmed diagnosis will change treatment decisions. Rapid molecular assays are the preferred diagnostic tests because they can be done at the point of care, are highly accurate, and have fast results. Treatment with one of four approved anti-influenza drugs may be considered if the patient presents within 48 hours of symptom onset. The benefit of treatment is greatest when antiviral therapy is started within 24 hours of symptom onset. These drugs decrease the duration of illness by about 24 hours in otherwise healthy patients and may decrease the risk of serious complications. No anti-influenza drug has been proven superior. Annual influenza vaccination is recommended for all people six months and older who do not have contraindications.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31845781

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  17 in total

Review 1.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

Review 2.  Platelets in Viral Infections - Brave Soldiers or Trojan Horses.

Authors:  Waltraud C Schrottmaier; Anna Schmuckenschlager; Anita Pirabe; Alice Assinger
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

3.  Social media effectiveness as a humanitarian response to mitigate influenza epidemic and COVID-19 pandemic.

Authors:  Sameer Kumar; Chong Xu; Nidhi Ghildayal; Charu Chandra; Muer Yang
Journal:  Ann Oper Res       Date:  2021-01-29       Impact factor: 4.820

Review 4.  Influenza and Influenza Vaccine: A Review.

Authors:  Cynthia Nypaver; Cynthia Dehlinger; Chelsea Carter
Journal:  J Midwifery Womens Health       Date:  2021-02-01       Impact factor: 2.388

5.  8-O-(E-p-methoxycinnamoyl)harpagide Inhibits Influenza A Virus Infection by Suppressing Intracellular Calcium.

Authors:  Eun-Bin Kwon; Hye-Jin Yang; Young-Soo Kim; Wei Li; Jang-Gi Choi
Journal:  Molecules       Date:  2021-02-15       Impact factor: 4.411

Review 6.  Influenza B infections in children: A review.

Authors:  Yellanthoor Ramesh Bhat
Journal:  World J Clin Pediatr       Date:  2020-11-19

7.  Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.

Authors:  Jiwon Yun; Jae Hyeon Park; Namhee Kim; Eun Youn Roh; Sue Shin; Jong Hyun Yoon; Taek Soo Kim; Hyunwoong Park
Journal:  J Korean Med Sci       Date:  2021-12-13       Impact factor: 2.153

8.  The Value of Combined Serum Amyloid A Protein and Neutrophil-to-Lymphocyte Ratio Testing in the Diagnosis and Treatment of Influenza A in Children.

Authors:  Shui Fu; Miao-Miao Zhang; Liang Zhang; Li-Feng Wu; Qi-Lei Hu
Journal:  Int J Gen Med       Date:  2021-07-22

Review 9.  Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.

Authors:  Hakimeh Baghaei Daemi; Muhammad Fakhar-E-Alam Kulyar; Xinlin He; Chengfei Li; Morteza Karimpour; Xiaomei Sun; Zhong Zou; Meilin Jin
Journal:  Viruses       Date:  2021-06-15       Impact factor: 5.048

Review 10.  Targeting the Host Response: Can We Manipulate Extracellular Matrix Metalloproteinase Activity to Improve Influenza Virus Infection Outcomes?

Authors:  Jess Pedrina; John Stambas
Journal:  Front Mol Biosci       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.